4651 - 4700 of 6295 Results
Title
Year
- Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum2019OPENTitle: Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat StriatumJournal Name: NeurosciencePublisher: Elsevier BVVol: 409Issue #:Start Page: 169End Page: 179Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuroscience.2019.04.033Best OA location URL: https://doi.org/10.1016/j.neuroscience.2019.04.033Citation Count: 47
-
OPENTitle: Targeting β-arrestin2 in the treatment ofl-DOPA–induced dyskinesia in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1502740112Best OA location URL: https://www.pnas.org/content/pnas/112/19/E2517.full.pdfCitation Count: 101
-
OPENTitle: Network spreading and local biological vulnerability in amyotrophic lateral sclerosisJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-025-08561-3Best OA location URL: https://www.nature.com/articles/s42003-025-08561-3.pdfCitation Count: 0
-
OPENTitle: Motor phenotype classification in moderate to advanced PD in BioFIND studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 178End Page: 183Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6774826Citation Count: 23
-
OPENTitle: A novel extended form of alpha-synuclein 3′UTR in the human brainJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-018-0371-xBest OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-018-0371-xCitation Count: 14
-
OPENTitle: Heritability estimates of cortical anatomy: The influence and reliability of different estimation strategiesJournal Name: NeuroImagePublisher: Elsevier BVVol: 178Issue #:Start Page: 78End Page: 91Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.05.014Best OA location URL: https://eprints.lancs.ac.uk/id/eprint/125120/1/1_s2.0_S1053811918304129_main.pdfCitation Count: 21
-
OPENTitle: PKCδ mediates paraquat-induced Nox1 expression in dopaminergic neuronsJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 437Issue #: 3Start Page: 380End Page: 385Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2013.06.085Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3759816Citation Count: 11
-
OPENTitle: A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cellsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00624-8Best OA location URL: https://www.nature.com/articles/s41531-023-00624-8.pdfCitation Count: 15
-
OPENTitle: Assessment of a prognostic MRI biomarker in early de novo Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 24Issue #:Start Page: 101986End Page: 101986Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101986Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101986Citation Count: 40
-
OPENTitle: Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site studyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1097End Page: 1104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.10.029Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.10.029Citation Count: 147
- Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain2014OPENTitle: Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrainJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1110End Page: 1120Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.047Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.07.047Citation Count: 22
-
OPENTitle: Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorderJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0073-1Best OA location URL: https://www.nature.com/articles/s41531-018-0073-1.pdfCitation Count: 30
- Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress2017OPENTitle: Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stressJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-017-0862-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-017-0862-1Citation Count: 30
-
OPENTitle: Kinase Domain Is a Dynamic Hub for Driving LRRK2 AllosteryJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2020.538219Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2020.538219/pdfCitation Count: 24
-
OPENTitle: Dual role of USP 30 in controlling basal pexophagy and mitophagyJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745595Best OA location URL: https://doi.org/10.15252/embr.201745595Citation Count: 153
-
OPENTitle: Pharmacological validation of TDO as a target for Parkinson’s diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 288Issue #: 14Start Page: 4311End Page: 4331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/febs.15721Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.15721Citation Count: 22
-
OPENTitle: Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicityJournal Name: Journal of AutoimmunityPublisher: Elsevier BVVol: 152Issue #:Start Page: 103390End Page: 103390Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jaut.2025.103390Best OA location URL: https://doi.org/10.1016/j.jaut.2025.103390Citation Count: 0
-
OPENTitle: Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.58997Best OA location URL: https://doi.org/10.7554/elife.58997Citation Count: 49
-
OPENTitle: Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonistsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 10Start Page: 2481End Page: 2488Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.03.102Best OA location URL: http://doi.org/10.1016/j.bmcl.2016.03.102Citation Count: 24
-
OPENTitle: The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domainJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 30Start Page: 14979End Page: 14988Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.1900289116Best OA location URL: https://escholarship.org/uc/item/2wj7c9h7Citation Count: 78
- Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease2020OPENTitle: Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 851End Page: 858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27993Best OA location URL: https://escholarship.org/uc/item/77c4k0xvCitation Count: 38
-
OPENTitle: Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic miceJournal Name: Neurobiology of Learning and MemoryPublisher: Elsevier BVVol: 142Issue #:Start Page: 182End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nlm.2017.05.001Citation Count: 13
-
OPENTitle: The AfrAbia+plus Parkinson's Disease Genomic ConsortiumJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 2Start Page: 140End Page: 141Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00453-2Best OA location URL: http://www.thelancet.com/article/S1474442223004532/pdfCitation Count: 4
-
OPENTitle: Autosomal Dominant Parkinson's Disease Caused by SNCA p.E46K Mutation in a Family with Russian AncestryJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 8Start Page: 1424End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29821Best OA location URL: https://doi.org/10.1002/mds.29821Citation Count: 3
-
OPENTitle: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27259Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27259Citation Count: 16
-
OPENTitle: Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00404-wBest OA location URL: https://escholarship.org/uc/item/83h7p6szCitation Count: 15
-
OPENTitle: Disruption of the LRRK2‐FADD Interface Using Constrained PeptidesJournal Name: Peptide SciencePublisher: WileyVol: 116Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/pep2.24374Best OA location URL: https://doi.org/10.1002/pep2.24374Citation Count: 0
-
OPENTitle: OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 174End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.009Best OA location URL: https://zenodo.org/record/3832127Citation Count: 17
-
OPENTitle: Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO ProteinsJournal Name: PROTEOMICSPublisher: WileyVol: 18Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/pmic.201700444Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pmic.201700444Citation Count: 44
-
OPENTitle: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2016.00174Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2016.00174/pdfCitation Count: 10
-
OPENTitle: Impaired Economy of Gait and Decreased Six-Minute Walk Distance in Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/241754Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/241754.pdfCitation Count: 36
-
OPENTitle: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the artJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-024-01144-2Best OA location URL: https://doi.org/10.1038/s41746-024-01144-2Citation Count: 14
- Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease2020OPENTitle: Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 4Start Page: 449End Page: 461Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51022Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51022Citation Count: 67
-
OPENTitle: Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 77Issue #: 2Start Page: 139End Page: 148Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlx110Best OA location URL: https://academic.oup.com/jnen/article-pdf/77/2/139/23373432/nlx110.pdfCitation Count: 47
- The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease2024OPENTitle: The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-65640-xBest OA location URL: https://doi.org/10.1038/s41598-024-65640-xCitation Count: 4
-
OPENTitle: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole PolinskiJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 16Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.050605Best OA location URL: https://journals.biologists.com/dmm/article-pdf/16/12/dmm050605/3311458/dmm050605.pdfCitation Count: 0
-
OPENTitle: White Matter Hyperintensities Related to Parkinson's Disease Executive FunctionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 6Start Page: 629End Page: 638Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.12956Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12956Citation Count: 47
-
OPENTitle: Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 1Start Page: 64End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(17)30400-3Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/148223504/Investigating_the_genetic_architecture_of_dementia_TROAKES_Publishedonline16December2017_GREEN_AAM.pdfCitation Count: 240
-
OPENTitle: Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1761End Page: 1767Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29124Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29124Citation Count: 7
-
OPENTitle: Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 303Issue #:Start Page: 95End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.01.015Citation Count: 39
-
OPENTitle: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating FactorsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 8Issue #: 3Start Page: 232End Page: 238Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.17294/2330-0698.1836Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1836&context=jpcrrCitation Count: 13
-
OPENTitle: Forecasts for the Attainment of Major Research Milestones in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1047End Page: 1055Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201933Best OA location URL: https://escholarship.mcgill.ca/concern/articles/5425kg39cCitation Count: 4
-
OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Best OA location URL: https://doi.org/10.1038/s41591-024-03101-8Citation Count: 16
-
OPENTitle: Reply: Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson’s disease and BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 2Start Page: e16End Page: e16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa369Best OA location URL: https://academic.oup.com/brain/article-pdf/144/2/e16/36454303/awaa369.pdfCitation Count: 0
-
OPENTitle: Care access and utilization among medicare beneficiaries living with Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00523-yBest OA location URL: https://www.nature.com/articles/s41531-023-00523-y.pdfCitation Count: 23
-
OPENTitle: Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1028End Page: 1039Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28934Best OA location URL: https://doi.org/10.1002/mds.28934Citation Count: 25
-
OPENTitle: Immunosuppressants and risk of Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 5Issue #: 7Start Page: 870End Page: 875Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.580Best OA location URL: https://doi.org/10.1002/acn3.580Citation Count: 79
-
OPENTitle: An Expanded Polyproline Domain Maintains Mutant Huntingtin Soluble in vivo and During AgingJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.721749Best OA location URL: https://doi.org/10.3389/fnmol.2021.721749Citation Count: 15
-
OPENTitle: A comprehensive cognitive analysis of cervical dystonia: A single centre studyJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 9Issue #:Start Page: 100226End Page: 100226Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100226Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100226Citation Count: 2
- Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease2021OPENTitle: Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1451End Page: 1455Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28525Best OA location URL: https://doi.org/10.1002/mds.28525Citation Count: 21